Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate whether 2 puffs of fixed combination of aerosolized
120 mcg salbutamol sulphate (equivalent to 100 mcg of the base) + 20 mcg ipratropium bromide
confers significant additional protection against metacholine induced bronchoconstriction in
asthmatic atopic patients when compared to 2 puffs of aerosolized 100 mcg salbutamol alone.